~~<i id='D4321FFDE9'><strike id='D4321FFDE9'><tt id='D4321FFDE9'><pre id='D4321FFDE9'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

knowledge

author：explore 2025-09-09 19:31:25 - browse：53

WASHINGTON — Back in 1980, when the Food and Drug Administration approved the use of lead acetate in hair dyes, little was known about the way skin absorbs toxic chemicals.

The skin — and the scalp in particular — were considered tough barriers to break, and many public health officials believed that even if small amounts of lead got through, or were inhaled, it couldn’t really hurt anyone.

But in science, 37 years is an eon. So a coalition of environmental groups, academics, and consumer advocates is pushing FDA to take lead acetate off the market. It is now permitted as a color additive.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Why the drug industry's warnings on the IRA's impact fall short

entertainment

leisure time

knowledge

Wikipedia

entertainment

MikeReddyforSTATIshouldbeirateanddespondentabouttheSupremeCourt’sscrappingofaffirmativeactioninadmis

WSS

Medicare to pay more for cardiac rehab in hospital outpatient clinics

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

EQRx, failed developer of low

How the messy conversation about Dolly changed bioethics

Pence says 'crackpot lawyers' told Trump what he wanted to hear

FDA weighs limits of animal data in assessing artificial wombs

hotspot

knowledge

entertainment

How to save PrEP access — and even expand it

Mitch McConnell episode has important public health takeaway

FDA approval of Sarepta Duchenne genetic therapy gives me hope

‘Oppenheimer’ and the risks of AI in health care

Trump demands the U.S. pay no more for drugs than other countries … again

New safety details link Apellis eye drug to rare cases of blindness

As demand for Covid shots wanes, Moderna seeks its next success

The high personal cost of affirmative action for Black doctors

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Akili changes sales model for its ADHD video game treatment

entertainment

Physician groups backed by private equity giant lobby on mergers

What to expect as Trump is arraigned on his Jan 6. indictment

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

What happened to the House vote on health price transparency?

Mitch McConnell episode has important public health takeaway

leisure time

knowledge

Wikipedia

entertainment